Transdermal administration of oestrogen/progestagen hormone replacement therapy
- 1 February 1990
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 335 (8685) , 310-312
- https://doi.org/10.1016/0140-6736(90)90605-5
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- A comprehensive evaluation of the heparin–manganese precipitation procedure for estimating high density lipoprotein cholesterolPublished by Elsevier ,2021
- Are fixed‐dose oestrogen/progestogen combinations ideal for all HRT users?BJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort studyBritish Journal of Cancer, 1989
- Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.BMJ, 1989
- Immunoturbidimetric assays for serum apolipoproteins A1 and B using Cobas Bio centrifugal analyser.Journal of Clinical Pathology, 1988
- Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.Circulation, 1987
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986
- Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapyBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: A comparison between progestogens and natural progesteroneAmerican Journal of Obstetrics and Gynecology, 1985
- Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal EndometriumNew England Journal of Medicine, 1981